Inventor · disambiguated record
Yanju Cheng
Also filed as: CHENG YANJU
1 granted patent·7 pending applications·0 citations·filing 2016–2022
9Inventor score
Files withCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD6NANJING SHUNXIN PHARMACEUTICAL CO LTD1NANJING SHUNXIN PHARMACEUTICALS CO LTD OF CHIATAI TIANQING PHARMACEUTICAL GROUP1
Top patents by PatentIndex Score
8 records- 0157US2020338519A1Method for preparing liposomeCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 0253US2024343815A1Pharmaceutical composition of anti-il4r antibody and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
- 0350US2023235057A1Bifunctional protein against pd-1 and tgf-betaCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 0449US2018361342A1Method for Preparing LiposomeCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Application pending·0 cites
- 0547US2023279138A1Novel bispecific anti-cd3/cd20 polypeptide complex formulationCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 0644US2024309080A1Pharmaceutical composition containing anti-tslp antibodyCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
- 0741US2022289825A1FUSION PROTEIN TARGETING PD-L1 AND TGF-ß AND USE THEREOFNANJING SHUNXIN PHARMACEUTICALS CO LTD OF CHIATAI TIANQING PHARMACEUTICAL GROUP·Filed 2020·Application pending·0 cites
- 0839US12150990B2Pharmaceutical composition of humanized monoclonal anti-PD-L1 antibodyNANJING SHUNXIN PHARMACEUTICAL CO LTD·Filed 2018·Granted Nov 26, 2024·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Yanju Cheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →